[144] Revolution Medicines, Inc. SEC Filing

Rhea-AI Filing Summary

Revolution Medicines insider sale reported. The filing lists sales by Jack Anders of 3,104 shares on 12/16/2025 and 10,000 shares on 01/07/2026, with reported proceeds of $239,288.60 and $980,000.00 respectively.

The notice also lists historical restricted stock unit grants with grant dates of 03/01/2022, 09/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025, showing grant quantities of 261, 225, 597, 593, and 458 shares.

Insights

Insider Transactions Compliance Expert

Form 144 lists routine Rule 144 sales by a reporting person with prior RSU grants disclosed.

The filing records two open-market dispositions by Jack Anders: $239,288.60 for 3,104 shares on 12/16/2025 and $980,000.00 for 10,000 shares on 01/07/2026. The notice also documents prior restricted stock unit grants across 2022–2025.

These filings are administrative notices required when restricted securities are sold under Rule 144; the listed grant dates and share amounts provide context about the source of the shares. Subsequent filings would show any further sales or changes in reported holdings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	2134	212525.06	198173397	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2022	Restricted stock unit grant	Issuer			261	03/01/2022	Services rendered
Common Stock	09/01/2022	Restricted stock unit grant	Issuer			225	09/01/2022	Services rendered
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			597	03/01/2023	Services rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			593	03/01/2024	Services rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			458	03/01/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jack Anders c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	12/16/2025	3104	239288.60
Jack Anders c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	01/07/2026	10000	980000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)